Difference between revisions of "Ephedra"
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
The Chinese botanical ephedra, or ma-huang, is sold as a dietary supplement in the United States. Ephedra is the common name for three principal species: Ephedra sinica, Ephedra equisentina, and Ephedra intermedia. The active compounds in the plant's stem (about 1.32% by weight) are the phenylalanine-derived alkaloids ephedrine, pseudoephedrine, phenylpropanolamine (norephedrine), and cathine (norpseudoephedrine)<ref>National Institutes of Health, [http://ods.od.nih.gov/factsheets/ephedraandephedrine.asp Ephedra and Ephedrine Alkaloids for Weight Loss and Athletic Performance], Office of Dietary Supplements</ref>. | The Chinese botanical ephedra, or ma-huang, is sold as a dietary supplement in the United States. Ephedra is the common name for three principal species: Ephedra sinica, Ephedra equisentina, and Ephedra intermedia. The active compounds in the plant's stem (about 1.32% by weight) are the phenylalanine-derived alkaloids ephedrine, pseudoephedrine, phenylpropanolamine (norephedrine), and cathine (norpseudoephedrine)<ref>National Institutes of Health, [http://ods.od.nih.gov/factsheets/ephedraandephedrine.asp Ephedra and Ephedrine Alkaloids for Weight Loss and Athletic Performance], Office of Dietary Supplements</ref>. | ||
| − | + | A systematic review of 117 studies found that ephedra and ephedrine promoted modest short-term weight loss (approximately 0.9 kg/month more than with placebo) but increased the risk of psychiatric, autonomic, gastrointestinal, and cardiac complications by a factor of 2.2 to 3.6.<ref>Shekelle et al, [http://www.bmj.com/cgi/reprint/327/7418/E222?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=ephedra&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT Ephedra], JAMA March 26, 2003;289:1537-1545</ref>. An analysis of adverse reactions reported to poison control centers found that products containing ephedra accounted for 64% of all adverse reactions to herbs in the United States, yet these products represented only 0.82% of herbal product sales<ref>Bent et al, [http://www.bmj.com/cgi/reprint/327/7418/E222?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&fulltext=ephedra&searchid=1&FIRSTINDEX=0&sortspec=date&resourcetype=HWCIT Ann Intern Med] March 18, 2003;138:468-471</ref>. | |
| − | A systematic review of 117 studies found that ephedra and ephedrine promoted modest | ||
==Notes== | ==Notes== | ||
Latest revision as of 16:50, 29 January 2010
The Chinese botanical ephedra, or ma-huang, is sold as a dietary supplement in the United States. Ephedra is the common name for three principal species: Ephedra sinica, Ephedra equisentina, and Ephedra intermedia. The active compounds in the plant's stem (about 1.32% by weight) are the phenylalanine-derived alkaloids ephedrine, pseudoephedrine, phenylpropanolamine (norephedrine), and cathine (norpseudoephedrine)[1].
A systematic review of 117 studies found that ephedra and ephedrine promoted modest short-term weight loss (approximately 0.9 kg/month more than with placebo) but increased the risk of psychiatric, autonomic, gastrointestinal, and cardiac complications by a factor of 2.2 to 3.6.[2]. An analysis of adverse reactions reported to poison control centers found that products containing ephedra accounted for 64% of all adverse reactions to herbs in the United States, yet these products represented only 0.82% of herbal product sales[3].
Notes
- ↑ National Institutes of Health, Ephedra and Ephedrine Alkaloids for Weight Loss and Athletic Performance, Office of Dietary Supplements
- ↑ Shekelle et al, Ephedra, JAMA March 26, 2003;289:1537-1545
- ↑ Bent et al, Ann Intern Med March 18, 2003;138:468-471
